Search

everythinglearnresearchcommunity

for

Search:↓

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Too much or too little selenium in the diet can cause hair loss and graying in mice.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Hair transplantation can lead to rare scalp complications, requiring careful follow-up and treatment.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

The protein aPKCλ is crucial for keeping hair follicle stem cells inactive and for hair growth and regeneration.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

New acne treatments show promise as alternatives to traditional therapies.

Graying hair happens due to aging and might be delayed by new treatments.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Tailor treatments for vitiligo to patient needs for best results.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.